Listed

Bluejay Diagnostics, Inc.

BJDXNasdaqCIK 1704287HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$2.3m, Q2 FY2026
Net income−$2.3m, Q2 FY2026
Bluejay Diagnostics, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Cost of revenue$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Gross profit$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$k1,397Research and development, Q3 FY2023, three months to 2023-09-30$1.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-07, accession 0001213900-24-095388.Report this figure1,286Research and development, Q4 FY2023, three months to 2023-12-31$1.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-31, accession 0001213900-25-026275. Derived: 12-month figure less the 9-month figure.Report this figure1,335Research and development, Q1 FY2024, three months to 2024-03-31$1.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-13, accession 0001213900-25-042633.Report this figure1,032Research and development, Q2 FY2024, three months to 2024-06-30$1.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0001213900-25-073064.Report this figure552Research and development, Q3 FY2024, three months to 2024-09-30$551.7k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-07, accession 0001213900-25-107599.Report this figure554Research and development, Q4 FY2024, three months to 2024-12-31$554.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-06, accession 0001213900-26-024616. Derived: 12-month figure less the 9-month figure.Report this figure785Research and development, Q1 FY2025, three months to 2025-03-31$784.8k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001213900-26-053328.Report this figure890Research and development, Q2 FY2025, three months to 2025-06-30$889.9k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001213900-26-088347.Report this figure786Research and development, Q3 FY2025, three months to 2025-09-30$785.6k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-07, accession 0001213900-25-107599.Report this figure586Research and development, Q4 FY2025, three months to 2025-12-31$586.1k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-06, accession 0001213900-26-024616. Derived: 12-month figure less the 9-month figure.Report this figure812Research and development, Q1 FY2026, three months to 2026-03-31$811.8k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-07, accession 0001213900-26-053328.Report this figure1,438Research and development, Q2 FY2026, three months to 2026-06-30$1.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001213900-26-088347.Report this figure
Selling, general and administrative$k(19.6)Selling, general and administrative, Q3 FY2023, three months to 2023-09-30−$19.6k. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2023-11-09, accession 0001213900-23-085215.Report this figure0.7Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$687. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2024-03-28, accession 0001213900-24-027305. Derived: 12-month figure less the 9-month figure.Report this figure6.4Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$6.4k. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-05-15, accession 0001213900-24-043735.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Operating income$k(2,341)Operating income, Q3 FY2023, three months to 2023-09-30−$2.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-07, accession 0001213900-24-095388.Report this figure(2,387)Operating income, Q4 FY2023, three months to 2023-12-31−$2.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-31, accession 0001213900-25-026275. Derived: 12-month figure less the 9-month figure.Report this figure(2,428)Operating income, Q1 FY2024, three months to 2024-03-31−$2.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-13, accession 0001213900-25-042633.Report this figure(1,895)Operating income, Q2 FY2024, three months to 2024-06-30−$1.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0001213900-25-073064.Report this figure(1,362)Operating income, Q3 FY2024, three months to 2024-09-30−$1.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-07, accession 0001213900-25-107599.Report this figure(1,485)Operating income, Q4 FY2024, three months to 2024-12-31−$1.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-06, accession 0001213900-26-024616. Derived: 12-month figure less the 9-month figure.Report this figure(1,889)Operating income, Q1 FY2025, three months to 2025-03-31−$1.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001213900-26-053328.Report this figure(1,985)Operating income, Q2 FY2025, three months to 2025-06-30−$2.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001213900-26-088347.Report this figure(1,617)Operating income, Q3 FY2025, three months to 2025-09-30−$1.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-07, accession 0001213900-25-107599.Report this figure(1,462)Operating income, Q4 FY2025, three months to 2025-12-31−$1.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-06, accession 0001213900-26-024616. Derived: 12-month figure less the 9-month figure.Report this figure(1,939)Operating income, Q1 FY2026, three months to 2026-03-31−$1.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001213900-26-053328.Report this figure(2,349)Operating income, Q2 FY2026, three months to 2026-06-30−$2.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001213900-26-088347.Report this figure
Interest expense$knot reportednot reportednot reported626Interest expense, Q2 FY2024, three months to 2024-06-30$626.5k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-07, accession 0001213900-25-073064.Report this figure186Interest expense, Q3 FY2024, three months to 2024-09-30$185.9k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-11-07, accession 0001213900-24-095388.Report this figure15.2Interest expense, Q4 FY2024, three months to 2024-12-31$15.2k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-06, accession 0001213900-26-024616. Derived: 12-month figure less the 9-month figure.Report this figurenot reported0.2Interest expense, Q2 FY2025, three months to 2025-06-30$222. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-07, accession 0001213900-25-073064.Report this figure0.2Interest expense, Q3 FY2025, three months to 2025-09-30$200. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-07, accession 0001213900-25-107599.Report this figure0.2Interest expense, Q4 FY2025, three months to 2025-12-31$187. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-06, accession 0001213900-26-024616. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported
Net income$k(2,298)Net income, Q3 FY2023, three months to 2023-09-30−$2.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-07, accession 0001213900-24-095388.Report this figure(2,303)Net income, Q4 FY2023, three months to 2023-12-31−$2.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-31, accession 0001213900-25-026275. Derived: 12-month figure less the 9-month figure.Report this figure(2,328)Net income, Q1 FY2024, three months to 2024-03-31−$2.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-07, accession 0001213900-25-107599.Report this figure(2,475)Net income, Q2 FY2024, three months to 2024-06-30−$2.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-07, accession 0001213900-25-107599.Report this figure(1,482)Net income, Q3 FY2024, three months to 2024-09-30−$1.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-07, accession 0001213900-25-107599.Report this figure(1,432)Net income, Q4 FY2024, three months to 2024-12-31−$1.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-06, accession 0001213900-26-024616. Derived: 12-month figure less the 9-month figure.Report this figure(1,864)Net income, Q1 FY2025, three months to 2025-03-31−$1.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001213900-26-088347.Report this figure(1,957)Net income, Q2 FY2025, three months to 2025-06-30−$2.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001213900-26-088347.Report this figure(1,598)Net income, Q3 FY2025, three months to 2025-09-30−$1.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-07, accession 0001213900-25-107599.Report this figure(1,430)Net income, Q4 FY2025, three months to 2025-12-31−$1.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-06, accession 0001213900-26-024616. Derived: 12-month figure less the 9-month figure.Report this figure(1,919)Net income, Q1 FY2026, three months to 2026-03-31−$1.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001213900-26-088347.Report this figure(2,324)Net income, Q2 FY2026, three months to 2026-06-30−$2.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001213900-26-088347.Report this figure
Diluted EPS$ per share(16.67)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$16.67 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-07, accession 0001213900-24-095388.Report this figurenot reported(394.76)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$394.76 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-13, accession 0001213900-25-042633.Report this figure(256.16)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$256.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-07, accession 0001213900-25-073064.Report this figure(76.94)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$76.94 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-07, accession 0001213900-25-107599.Report this figurenot reported(13.46)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$13.46 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001213900-26-053328.Report this figure(5.64)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$5.64 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-12, accession 0001213900-26-088347.Report this figure(1.01)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$1.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-07, accession 0001213900-25-107599.Report this figurenot reported(1.95)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$1.95 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001213900-26-053328.Report this figure(1.12)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$1.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-12, accession 0001213900-26-088347.Report this figure
Basic EPS$ per share(16.67)Basic EPS, Q3 FY2023, three months to 2023-09-30−$16.67 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-07, accession 0001213900-24-095388.Report this figurenot reported(394.76)Basic EPS, Q1 FY2024, three months to 2024-03-31−$394.76 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-13, accession 0001213900-25-042633.Report this figure(256.16)Basic EPS, Q2 FY2024, three months to 2024-06-30−$256.16 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0001213900-25-073064.Report this figure(76.94)Basic EPS, Q3 FY2024, three months to 2024-09-30−$76.94 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-07, accession 0001213900-25-107599.Report this figurenot reported(13.46)Basic EPS, Q1 FY2025, three months to 2025-03-31−$13.46 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001213900-26-053328.Report this figure(5.64)Basic EPS, Q2 FY2025, three months to 2025-06-30−$5.64 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001213900-26-088347.Report this figure(1.01)Basic EPS, Q3 FY2025, three months to 2025-09-30−$1.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-07, accession 0001213900-25-107599.Report this figurenot reported(1.95)Basic EPS, Q1 FY2026, three months to 2026-03-31−$1.95 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-07, accession 0001213900-26-053328.Report this figure(1.12)Basic EPS, Q2 FY2026, three months to 2026-06-30−$1.12 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001213900-26-088347.Report this figure

Balance sheet

Cash and equivalents$9.6m, Q2 FY2026
Shareholders' equity$9.4m, Q2 FY2026
Bluejay Diagnostics, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m5.1Cash and equivalents, Q3 FY2023, at 2023-09-30$5.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-09, accession 0001213900-23-085215.Report this figure2.2Cash and equivalents, FY2023, at 2023-12-31$2.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-31, accession 0001213900-25-026275.Report this figure2.7Cash and equivalents, Q1 FY2024, at 2024-03-31$2.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-15, accession 0001213900-24-043735.Report this figure8.1Cash and equivalents, Q2 FY2024, at 2024-06-30$8.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-14, accession 0001213900-24-069110.Report this figure5.8Cash and equivalents, Q3 FY2024, at 2024-09-30$5.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0001213900-24-095388.Report this figure4.3Cash and equivalents, FY2024, at 2024-12-31$4.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-06, accession 0001213900-26-024616.Report this figure3.1Cash and equivalents, Q1 FY2025, at 2025-03-31$3.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-13, accession 0001213900-25-042633.Report this figure4.4Cash and equivalents, Q2 FY2025, at 2025-06-30$4.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0001213900-25-073064.Report this figure3.1Cash and equivalents, Q3 FY2025, at 2025-09-30$3.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-07, accession 0001213900-25-107599.Report this figure5.2Cash and equivalents, FY2025, at 2025-12-31$5.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001213900-26-088347.Report this figure3.7Cash and equivalents, Q1 FY2026, at 2026-03-31$3.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-07, accession 0001213900-26-053328.Report this figure9.6Cash and equivalents, Q2 FY2026, at 2026-06-30$9.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001213900-26-088347.Report this figure
Current assets$m6.5Current assets, Q3 FY2023, at 2023-09-30$6.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-09, accession 0001213900-23-085215.Report this figure3.2Current assets, FY2023, at 2023-12-31$3.2m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-31, accession 0001213900-25-026275.Report this figure3.4Current assets, Q1 FY2024, at 2024-03-31$3.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-15, accession 0001213900-24-043735.Report this figure9.0Current assets, Q2 FY2024, at 2024-06-30$9.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-14, accession 0001213900-24-069110.Report this figure6.6Current assets, Q3 FY2024, at 2024-09-30$6.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0001213900-24-095388.Report this figure4.9Current assets, FY2024, at 2024-12-31$4.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-06, accession 0001213900-26-024616.Report this figure3.6Current assets, Q1 FY2025, at 2025-03-31$3.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-13, accession 0001213900-25-042633.Report this figure4.7Current assets, Q2 FY2025, at 2025-06-30$4.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0001213900-25-073064.Report this figure3.4Current assets, Q3 FY2025, at 2025-09-30$3.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-07, accession 0001213900-25-107599.Report this figure5.5Current assets, FY2025, at 2025-12-31$5.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001213900-26-088347.Report this figure4.0Current assets, Q1 FY2026, at 2026-03-31$4.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-07, accession 0001213900-26-053328.Report this figure9.8Current assets, Q2 FY2026, at 2026-06-30$9.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001213900-26-088347.Report this figure
Total assets$m8.2Total assets, Q3 FY2023, at 2023-09-30$8.2m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-09, accession 0001213900-23-085215.Report this figure4.9Total assets, FY2023, at 2023-12-31$4.9m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-31, accession 0001213900-25-026275.Report this figure5.1Total assets, Q1 FY2024, at 2024-03-31$5.1m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-15, accession 0001213900-24-043735.Report this figure10.9Total assets, Q2 FY2024, at 2024-06-30$10.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-14, accession 0001213900-24-069110.Report this figure8.4Total assets, Q3 FY2024, at 2024-09-30$8.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0001213900-24-095388.Report this figure6.7Total assets, FY2024, at 2024-12-31$6.7m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-06, accession 0001213900-26-024616.Report this figure5.3Total assets, Q1 FY2025, at 2025-03-31$5.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-13, accession 0001213900-25-042633.Report this figure6.4Total assets, Q2 FY2025, at 2025-06-30$6.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0001213900-25-073064.Report this figure4.9Total assets, Q3 FY2025, at 2025-09-30$4.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-07, accession 0001213900-25-107599.Report this figure7.1Total assets, FY2025, at 2025-12-31$7.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001213900-26-088347.Report this figure5.6Total assets, Q1 FY2026, at 2026-03-31$5.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-07, accession 0001213900-26-053328.Report this figure11.5Total assets, Q2 FY2026, at 2026-06-30$11.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001213900-26-088347.Report this figure
Current liabilities$m2.8Current liabilities, Q3 FY2023, at 2023-09-30$2.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-09, accession 0001213900-23-085215.Report this figure1.8Current liabilities, FY2023, at 2023-12-31$1.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-31, accession 0001213900-25-026275.Report this figure1.5Current liabilities, Q1 FY2024, at 2024-03-31$1.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-15, accession 0001213900-24-043735.Report this figure2.1Current liabilities, Q2 FY2024, at 2024-06-30$2.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-14, accession 0001213900-24-069110.Report this figure1.0Current liabilities, Q3 FY2024, at 2024-09-30$1.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0001213900-24-095388.Report this figure0.8Current liabilities, FY2024, at 2024-12-31$810.4k. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-06, accession 0001213900-26-024616.Report this figure1.3Current liabilities, Q1 FY2025, at 2025-03-31$1.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-13, accession 0001213900-25-042633.Report this figure1.0Current liabilities, Q2 FY2025, at 2025-06-30$1.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0001213900-25-073064.Report this figure1.1Current liabilities, Q3 FY2025, at 2025-09-30$1.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-07, accession 0001213900-25-107599.Report this figure1.1Current liabilities, FY2025, at 2025-12-31$1.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001213900-26-088347.Report this figure1.4Current liabilities, Q1 FY2026, at 2026-03-31$1.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-07, accession 0001213900-26-053328.Report this figure2.1Current liabilities, Q2 FY2026, at 2026-06-30$2.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001213900-26-088347.Report this figure
Total liabilities$m3.0Total liabilities, Q3 FY2023, at 2023-09-30$3.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-09, accession 0001213900-23-085215.Report this figure2.0Total liabilities, FY2023, at 2023-12-31$2.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-31, accession 0001213900-25-026275.Report this figure1.7Total liabilities, Q1 FY2024, at 2024-03-31$1.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-15, accession 0001213900-24-043735.Report this figure2.2Total liabilities, Q2 FY2024, at 2024-06-30$2.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-14, accession 0001213900-24-069110.Report this figure1.2Total liabilities, Q3 FY2024, at 2024-09-30$1.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0001213900-24-095388.Report this figure0.9Total liabilities, FY2024, at 2024-12-31$927.9k. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-06, accession 0001213900-26-024616.Report this figure1.4Total liabilities, Q1 FY2025, at 2025-03-31$1.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-13, accession 0001213900-25-042633.Report this figure1.1Total liabilities, Q2 FY2025, at 2025-06-30$1.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-07, accession 0001213900-25-073064.Report this figure1.2Total liabilities, Q3 FY2025, at 2025-09-30$1.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-07, accession 0001213900-25-107599.Report this figure1.1Total liabilities, FY2025, at 2025-12-31$1.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-12, accession 0001213900-26-088347.Report this figure1.4Total liabilities, Q1 FY2026, at 2026-03-31$1.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-07, accession 0001213900-26-053328.Report this figure2.1Total liabilities, Q2 FY2026, at 2026-06-30$2.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-12, accession 0001213900-26-088347.Report this figure
Shareholders' equity$m5.2Shareholders' equity, Q3 FY2023, at 2023-09-30$5.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-07, accession 0001213900-24-095388.Report this figure2.9Shareholders' equity, FY2023, at 2023-12-31$2.9m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-06, accession 0001213900-26-024616.Report this figure3.4Shareholders' equity, Q1 FY2024, at 2024-03-31$3.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-07, accession 0001213900-25-107599.Report this figure8.6Shareholders' equity, Q2 FY2024, at 2024-06-30$8.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-07, accession 0001213900-25-107599.Report this figure7.2Shareholders' equity, Q3 FY2024, at 2024-09-30$7.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-07, accession 0001213900-25-107599.Report this figure5.7Shareholders' equity, FY2024, at 2024-12-31$5.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001213900-26-088347.Report this figure3.9Shareholders' equity, Q1 FY2025, at 2025-03-31$3.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001213900-26-088347.Report this figure5.3Shareholders' equity, Q2 FY2025, at 2025-06-30$5.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001213900-26-088347.Report this figure3.7Shareholders' equity, Q3 FY2025, at 2025-09-30$3.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-07, accession 0001213900-25-107599.Report this figure6.0Shareholders' equity, FY2025, at 2025-12-31$6.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001213900-26-088347.Report this figure4.2Shareholders' equity, Q1 FY2026, at 2026-03-31$4.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001213900-26-088347.Report this figure9.4Shareholders' equity, Q2 FY2026, at 2026-06-30$9.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001213900-26-088347.Report this figure

Cash flow

Operating cash flow−$1.5m, Q2 FY2026
Capital expenditure$142.8k, Q2 FY2026
Bluejay Diagnostics, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$k(1,125)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$1.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0001213900-24-095388. Derived: 9-month figure less the 6-month figure.Report this figure(2,777)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$2.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-31, accession 0001213900-25-026275. Derived: 12-month figure less the 9-month figure.Report this figure(2,300)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$2.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-13, accession 0001213900-25-042633.Report this figure(1,915)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$1.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0001213900-25-073064. Derived: 6-month figure less the 3-month figure.Report this figure(2,155)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$2.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-07, accession 0001213900-25-107599. Derived: 9-month figure less the 6-month figure.Report this figure(1,451)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$1.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-06, accession 0001213900-26-024616. Derived: 12-month figure less the 9-month figure.Report this figure(1,185)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$1.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001213900-26-053328.Report this figure(2,054)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$2.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001213900-26-088347. Derived: 6-month figure less the 3-month figure.Report this figure(1,360)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$1.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-07, accession 0001213900-25-107599. Derived: 9-month figure less the 6-month figure.Report this figure(1,455)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$1.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-06, accession 0001213900-26-024616. Derived: 12-month figure less the 9-month figure.Report this figure(1,589)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$1.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001213900-26-053328.Report this figure(1,499)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$1.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001213900-26-088347. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$k74.5Capital expenditure, Q3 FY2023, three months to 2023-09-30$74.5k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-07, accession 0001213900-24-095388. Derived: 9-month figure less the 6-month figure.Report this figure87.9Capital expenditure, Q4 FY2023, three months to 2023-12-31$87.9k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-31, accession 0001213900-25-026275. Derived: 12-month figure less the 9-month figure.Report this figure35.4Capital expenditure, Q1 FY2024, three months to 2024-03-31$35.4k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-13, accession 0001213900-25-042633.Report this figure270Capital expenditure, Q2 FY2024, three months to 2024-06-30$270.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-07, accession 0001213900-25-073064. Derived: 6-month figure less the 3-month figure.Report this figure0.2Capital expenditure, Q3 FY2024, three months to 2024-09-30$227. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-07, accession 0001213900-25-107599. Derived: 9-month figure less the 6-month figure.Report this figure1.1Capital expenditure, Q4 FY2024, three months to 2024-12-31$1.1k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-06, accession 0001213900-26-024616. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reported19.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$19.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001213900-26-053328.Report this figure143Capital expenditure, Q2 FY2026, three months to 2026-06-30$142.8k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-12, accession 0001213900-26-088347. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$knot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)2.08m, Q2 FY2026
Bluejay Diagnostics, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)k shares1,008Diluted shares (weighted), Q3 FY2022, three months to 2022-09-301,007,617 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-09, accession 0001213900-23-085215.Report this figure1,019Diluted shares (weighted), Q1 FY2023, three months to 2023-03-311,018,755 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-15, accession 0001213900-24-043735.Report this figure128Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30127,881 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-14, accession 0001213900-24-069110.Report this figure138Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30137,871 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0001213900-24-095388.Report this figure5.9Diluted shares (weighted), Q1 FY2024, three months to 2024-03-315,898 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-13, accession 0001213900-25-042633.Report this figure9.7Diluted shares (weighted), Q2 FY2024, three months to 2024-06-309,663 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-07, accession 0001213900-25-073064.Report this figure191Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30191,117 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-07, accession 0001213900-25-107599.Report this figure139Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31138,503 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001213900-26-053328.Report this figure347Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30346,780 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-12, accession 0001213900-26-088347.Report this figure1,575Diluted shares (weighted), Q3 FY2025, three months to 2025-09-301,574,535 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-07, accession 0001213900-25-107599.Report this figure985Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31984,668 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-07, accession 0001213900-26-053328.Report this figure2,079Diluted shares (weighted), Q2 FY2026, three months to 2026-06-302,079,263 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-12, accession 0001213900-26-088347.Report this figure

Shares outstanding: 4.47mShares outstanding, period not labelled, at 2026-08-074,468,051 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-12, accession 0001213900-26-088347.Report this figure at Aug 7, 2026, from the cover of the 10-Q filed Aug 12, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. Listed shows no prices and gives no investment advice.